Jingi Ahmadou M, Tankeu Aurel T, Ateba Narcisse Assene, Noubiap Jean Jacques
Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, Yaoundé, Cameroon.
National Obesity Center, Yaoundé Central Hospital, Yaoundé, Cameroon.
BMC Endocr Disord. 2017 Oct 10;17(1):63. doi: 10.1186/s12902-017-0213-3.
Insulin treatment has been associated with a paradoxical worsening of diabetes retinopathy since many years in European cohorts. Recently, this issue has been stressed by some studies conducted in other parts of the world. However, the mechanism underlying such evolution is not well understood. An osmotic theory has been evocated but failed to explain the clinical features of the disease. Considering recent findings from basic and clinical research, we discuss the possibility of a synergistic hypothesis based on the simultaneous action of insulin and vascular endothelial growth factor on eye blood vessels. We postulate that exogenous insulin could act synergistically with the vascular endothelial growth factor expressed by ischemic retina so as to trigger vascular proliferation and the worsening of diabetes retinopathy.
多年来,在欧洲队列研究中,胰岛素治疗一直与糖尿病视网膜病变的反常恶化有关。最近,世界其他地区进行的一些研究也强调了这个问题。然而,这种病情演变背后的机制尚未完全明确。曾有人提出一种渗透理论,但该理论无法解释该疾病的临床特征。基于基础研究和临床研究的最新发现,我们讨论了一种协同假说的可能性,该假说基于胰岛素和血管内皮生长因子对眼部血管的同时作用。我们推测,外源性胰岛素可能与缺血视网膜表达的血管内皮生长因子协同作用,从而引发血管增殖和糖尿病视网膜病变的恶化。